Asthma: all 4,012 studies
Page 38 of 41. Open to participants first (515), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy Study of Omalizumab Given Prior to ImmunotherapyCompletedNCT00329381Phase 4
- Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable TabletsCompletedNCT00328718Phase 3
- Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible AsthmaCompletedNCT00327808Phase 2
- Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg FormoterolCompletedNCT00327353Phase 4
- Assessment Of Disease Pathology And Key Therapeutic Targets In Severe AsthmaTerminatedNCT00327197Phase 1
- Study of Efficacy of Phenytoin in Therapy of Patients With Bronchial AsthmaCompletedNCT00327028Phase 4
- Prevention of Asthma Relapse After Discharge From EmergencyCompletedNCT00326053Phase 3
- Study of Oglemilast for the Treatment of AsthmaCompletedNCT00322686Phase 2
- Study of Oglemilast for the Prevention of Asthma.CompletedNCT00322283Phase 2
- Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic AsthmaCompletedNCT00320034Phase 2
- Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)CompletedNCT00319488Not applicable
- Real Life Effectiveness in Asthma of Symbicort Single Inhaler TherapyCompletedNCT00319306Phase 3
- Treatment of Ragweed-Allergic Asthma With an Immunostimulatory DrugTerminatedNCT00318747Phase 2
- The Effect Of AVANDIA On The Late Asthmatic ResponseCompletedNCT00318630Phase 1
- Health2006 - an Observational Study of Cardiovascular Disease, Diabetes, Asthma and AllergyCompletedNCT00316667
- Viapaed Study In Children And Adolescents With AsthmaCompletedNCT00315744Phase 4
- Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)CompletedNCT00314509Phase 2
- Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen OxideStatus unknownNCT00312312Not applicable
- Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust MiteWithdrawnNCT00311051Phase 2/3
- Effect of Age and Device on Delivery of FluticasoneCompletedNCT00308932Phase 4
- Impact of Anti-static Chamber/MaskCompletedNCT00307970Phase 4
- Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)CompletedNCT00305461Phase 3
- HealthSpark 2: Improving Asthma Care for Preschool ChildrenCompletedNCT00304304Not applicable
- Safety Study of Zileuton Injection in Patients With AsthmaCompletedNCT00299065Phase 1/2
- Study Of Patients With Allergic Rhinitis And AsthmaCompletedNCT00296530Phase 4
- Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent AsthmaTerminatedNCT00295737Not applicable
- The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)CompletedNCT00292877Phase 2
- Relative Potency of Inhaled CorticosteroidsCompletedNCT00292838Phase 4
- Statin Treatment in Patients With AsthmaTerminatedNCT00292201Phase 2
- Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination ProductCompletedNCT00291382Phase 4
- SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent AsthmaCompletedNCT00290264Phase 3
- SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild AsthmaCompletedNCT00288379Phase 3
- Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy AsthmaStatus unknownNCT00286416Not applicable
- Asthma In-Home Monitoring (AIM) TrialCompletedNCT00282516Not applicable
- Center for Reducing Asthma Disparities - Northwestern University/Cook County Hospital CentersCompletedNCT00281177Not applicable
- Center for Reducing Asthma Disparities - Meharry/Vanderbilt CentersCompletedNCT00281151
- Center for Reducing Asthma Disparities - Rhode Island/Puerto Rico CentersCompletedNCT00281138
- Center for Reducing Asthma Disparities - Howard/Hopkins CentersCompletedNCT00281112
- Center for Reducing Asthma Disparities - Harvard University/Boston Area Community Health CentersCompletedNCT00281086
- Asthma Management Project University LeidenCompletedNCT00279188Not applicable
- Towards Restoring the Physiological Inhibition of Airway Narrowing in AsthmaStatus unknownNCT00279136
- TNF-alpha Directed Therapy in AsthmaCompletedNCT00278083Phase 2
- TNF Alpha in Refractory AsthmaCompletedNCT00276029Not applicable
- TELICAST : Telithromycin in Acute Exacerbations of AsthmaCompletedNCT00273520Phase 3
- Study In Asthma ControlTerminatedNCT00273026Phase 4
- Study With GW274150 In Patients With Mild AsthmaCompletedNCT00273013Phase 1
- Effect of Budesonide / Formoterol Combination in Repeated AMP ProvocationsCompletedNCT00272753Phase 4
- Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and CaregiverCompletedNCT00272727Not applicable
- Pediatric Asthma Controller Trial (PACT)CompletedNCT00272506Phase 3
- Prevention of Early Asthma in Kids (PEAK)CompletedNCT00272441Not applicable
- Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent AsthmaCompletedNCT00270348Phase 3
- Increasing Adherence to Asthma Medication in Urban TeensCompletedNCT00269282Not applicable
- Stress, Environment, and Genetics in Urban Children With AsthmaCompletedNCT00269256
- Evaluation of the Emergency Department Asthma Care ProjectCompletedNCT00268580Not applicable
- Multiple Dose ASM8 in Mild AsthmaticsCompletedNCT00264966Phase 1/2
- Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial AsthmaCompletedNCT00263640Phase 3
- Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-StudyCompletedNCT00263159Not applicable
- Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in AsthmaticsTerminatedNCT00262652Phase 1/2
- Elite Sport and Development of AsthmaCompletedNCT00262587Phase 4
- The Use of Inflammatory Markers to Guide Therapy in Children With Severe AsthmaCompletedNCT00262340Not applicable
- SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and AdultsCompletedNCT00259792Phase 3
- SHARE - Symbicort and Health Economics in a Real Life EvaluationCompletedNCT00259766Phase 3
- Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With AsthmaCompletedNCT00255255Phase 3
- Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent AsthmaCompletedNCT00254956Phase 3
- DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in AdultsCompletedNCT00252863Phase 3
- STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent AsthmaCompletedNCT00252824Phase 3
- Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic PatientsCompletedNCT00252785Phase 3
- Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected AsthmaticsCompletedNCT00252291Phase 3
- A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe AsthmaCompletedNCT00252135
- Writing About Disease: Effect on Rehabilitation?CompletedNCT00251420Not applicable
- Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07).CompletedNCT00246922Phase 3
- ASTHMA (AntibioticS To Help Manage Asthma) Pilot StudyCompletedNCT00245908Phase 3
- A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®CompletedNCT00244608Phase 3
- Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mgCompletedNCT00242775Phase 3
- MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and AdultsCompletedNCT00242411Phase 4
- A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced AsthmaWithdrawnNCT00242359Phase 4
- Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05).CompletedNCT00242307Phase 2/3
- Family Approach to Managing Asthma in Early TeensCompletedNCT00241852Phase 3
- Air Pollution, Inflammation, and New Onset AsthmaCompletedNCT00241696
- Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With AsthmaCompletedNCT00238927Phase 4
- Randomised Controlled Trial of a Multi-faceted Community-based Intervention to Improve Asthma in ChildrenCompletedNCT00238888Phase 4
- SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & AdultsCompletedNCT00238784Phase 3
- A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.Status unknownNCT00237068Phase 4
- Symbicort Single Inhaler Therapy for Asthma in a General Practice SettingCompletedNCT00235911Phase 3
- Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BIDCompletedNCT00235053Phase 4
- PreAsthmaControl (PAC)CompletedNCT00234390Phase 4
- Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid SuppressionCompletedNCT00234117Not applicable
- Pulmicort Asthma Prevention (Post-PAC)CompletedNCT00233584Not applicable
- Influence of Data Collection Mode on Self-Report Validity of Asthma Therapy AdherenceCompletedNCT00233233Not applicable
- Adherence Intervention for Minority Children With AsthmaCompletedNCT00233181Not applicable
- Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic AsthmaCompletedNCT00232999Phase 2
- Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial AsthmaCompletedNCT00232648Phase 3
- Study of Omalizumab in Moderate to Severe Bronchial AsthmaCompletedNCT00232050Phase 3
- A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic WomenCompletedNCT00228475Phase 4
- Pilot Study of Changing Exercise and Physical Activity Behavior in Asthma PatientsCompletedNCT00227162Not applicable
- Soluble CD23 Expression in Asthma Patients Treated With OMATerminatedNCT00226200Not applicable
- Impact of Caregiver Depression on Asthma in the ChildCompletedNCT00223288
- Air Cleaners for Children and Adolescents With Asthma and Dog AllergyCompletedNCT00220753Not applicable
- Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.CompletedNCT00219323Phase 3
- Nebulizer Intervention for Minority Children With AsthmaCompletedNCT00218816Phase 3